These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26819931)

  • 1. Enhancement of the Oral Bioavailability of Fexofenadine Hydrochloride via Cremophor(®) El-Based Liquisolid Tablets.
    Yehia SA; El-Ridi MS; Tadros MI; El-Sherif NG
    Adv Pharm Bull; 2015 Nov; 5(4):569-81. PubMed ID: 26819931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenylalanine-free taste-masked orodispersible tablets of fexofenadine hydrochloride: development, in vitro evaluation and in vivo estimation of the drug pharmacokinetics in healthy human volunteers.
    Yehia SA; El-Ridi MS; Tadros MI; El-Sherif NG
    Pharm Dev Technol; 2015; 20(5):528-39. PubMed ID: 24490806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of liquisolid formulations on dissolution of naproxen.
    Tiong N; Elkordy AA
    Eur J Pharm Biopharm; 2009 Nov; 73(3):373-84. PubMed ID: 19679184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquisolid technique to enhance and to sustain griseofulvin dissolution: effect of choice of non-volatile liquid vehicles.
    Elkordy AA; Essa EA; Dhuppad S; Jammigumpula P
    Int J Pharm; 2012 Sep; 434(1-2):122-32. PubMed ID: 22677418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced Oral Bioavailability of Etodolac by the Liquisolid Compact Technique: Optimisation, In-Vitro and In-Vivo Evaluation.
    Pathak BK; Raghav M; Thakkar AR; Vyas BA; Shah PJ
    Curr Drug Deliv; 2021; 18(4):471-486. PubMed ID: 33106143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of famotidine dissolution rate through liquisolid tablets formulation: in vitro and in vivo evaluation.
    Fahmy RH; Kassem MA
    Eur J Pharm Biopharm; 2008 Aug; 69(3):993-1003. PubMed ID: 18396390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of hydrogen bond formation/replacement on solubility characteristics, gastric permeation and pharmacokinetics of curcumin by application of powder solution technology.
    Sharma V; Pathak K
    Acta Pharm Sin B; 2016 Nov; 6(6):600-613. PubMed ID: 27818928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquisolid Tablets for Dissolution Enhancement of a Hypolipidemic Drug.
    Patel DS; Pipaliya RM; Surti N
    Indian J Pharm Sci; 2015; 77(3):290-8. PubMed ID: 26180274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation factors affecting the release of ezetimibe from different liquisolid compacts.
    Khanfar M; Sheikh Salem M; Hawari R
    Pharm Dev Technol; 2013; 18(2):417-27. PubMed ID: 22530561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Liquisolid technique for enhancement of dissolution prosperities of tanshinone II(A)].
    Liu XQ; Meng QJ; Xu XL; Zhao J; Yang H; Yi H
    Zhongguo Zhong Yao Za Zhi; 2015 Dec; 40(24):4840-6. PubMed ID: 27245032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquisolid systems to improve the dissolution of furosemide.
    Akinlade B; Elkordy AA; Essa EA; Elhagar S
    Sci Pharm; 2010; 78(2):325-44. PubMed ID: 21179350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suitability of various excipients as carrier and coating materials for liquisolid compacts.
    Hentzschel CM; Sakmann A; Leopold CS
    Drug Dev Ind Pharm; 2011 Oct; 37(10):1200-7. PubMed ID: 21449826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation and characterization of ketoprofen liquisolid compacts by Box-Behnken design.
    Vittal GV; Deveswaran R; Bharath S; Basavaraj B; Madhavan V
    Int J Pharm Investig; 2012 Jul; 2(3):150-6. PubMed ID: 23373006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Development of Self-nanoemulsifying Liquisolid Tablets to Improve the Dissolution of Simvastatin.
    Elkadi S; Elsamaligy S; Al-Suwayeh S; Mahmoud H
    AAPS PharmSciTech; 2017 Oct; 18(7):2586-2597. PubMed ID: 28236269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of Curcuma comosa tablets using liquisolid techniques: In vitro and in vivo evaluation.
    Jaipakdee N; Limpongsa E; Sripanidkulchai BO; Piyachaturawat P
    Int J Pharm; 2018 Dec; 553(1-2):157-168. PubMed ID: 30316793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liquisolid technique as a new approach to sustain propranolol hydrochloride release from tablet matrices.
    Javadzadeh Y; Musaalrezaei L; Nokhodchi A
    Int J Pharm; 2008 Oct; 362(1-2):102-8. PubMed ID: 18647643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of liquisolid technology for enhancing solubility and dissolution of rosuvastatin.
    Kamble PR; Shaikh KS; Chaudhari PD
    Adv Pharm Bull; 2014; 4(2):197-204. PubMed ID: 24511485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olanzapine Liquisolid Tablets Using Kolliphor EL with Improved Flowability and Bioavailability:
    Korni RD; Gonugunta CSR
    Turk J Pharm Sci; 2024 Mar; 21(1):52-61. PubMed ID: 38529549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of formulation parameters on dissolution rate enhancement of glyburide using liquisolid technique.
    Singh SK; Srinivasan KK; Gowthamarajan K; Prakash D; Gaikwad NB; Singare DS
    Drug Dev Ind Pharm; 2012 Aug; 38(8):961-70. PubMed ID: 22251080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of griseofulvin release from liquisolid compacts.
    Hentzschel CM; Alnaief M; Smirnova I; Sakmann A; Leopold CS
    Eur J Pharm Biopharm; 2012 Jan; 80(1):130-5. PubMed ID: 21846502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.